Moderna Covid vaccine candidate almost 95% effective, trials show

      Comments Off on Moderna Covid vaccine candidate almost 95% effective, trials show




Share This Story

US-based biotech firm is latest to reveal impressive results from phase 3 trials of jab

The race for a coronavirus vaccine has received another shot in the arm with the US biotech firm Moderna becoming the latest to reveal impressive results from phase 3 trials of its jab.

An interim analysis released on Monday, and based on 95 patients with confirmed Covid infections, found the candidate vaccine has an efficacy of 94.5%. The company said it planned to apply to the US regulator, the Food and Drug Administration, for emergency-use authorisation in the coming weeks. In the analysis, 90 of the patients received the placebo with the remaining five the vaccine.

Continue reading…